β-Lactams and β-lactamase inhibitors: an overview

K Bush, PA Bradford - Cold Spring …, 2016 - perspectivesinmedicine.cshlp.org
β-Lactams are the most widely used class of antibiotics. Since the discovery of
benzylpenicillin in the 1920s, thousands of new penicillin derivatives and related β-lactam …

Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance

RR Watkins, KM Papp-Wallace, SM Drawz… - Frontiers in …, 2013 - frontiersin.org
The increasing incidence and prevalence of multi-drug resistance (MDR) among
contemporary Gram-negative bacteria represents a significant threat to human health. Since …

Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria

K Bush, JF Fisher - Annual review of microbiology, 2011 - annualreviews.org
β-Lactamase evolution presents to the infectious disease community a major challenge in
the treatment of infections caused by multidrug-resistant gram-negative bacteria. Because …

New promising β-lactamase inhibitors for clinical use

I Olsen - European Journal of Clinical Microbiology & Infectious …, 2015 - Springer
Clavulanate, sulbactam, and tazobactam have been used extensively for the last 30 years,
together with β-lactam antibiotics, to inhibit the effect of β-lactamases. Although they have …

New β-lactam antibiotics and β-lactamase inhibitors

K Bush, MJ Macielag - Expert opinion on therapeutic patents, 2010 - Taylor & Francis
Importance of the field: β-Lactam antibiotics are among the most frequently prescribed
antibiotics used to treat bacterial infections. However, their utility is being threatened by the …

Three decades of β-lactamase inhibitors

SM Drawz, RA Bonomo - Clinical microbiology reviews, 2010 - Am Soc Microbiol
Since the introduction of penicillin, β-lactam antibiotics have been the antimicrobial agents
of choice. Unfortunately, the efficacy of these life-saving antibiotics is significantly threatened …

Old and new beta-lactamase inhibitors: molecular structure, mechanism of action, and clinical use

D Carcione, C Siracusa, A Sulejmani, V Leoni, J Intra - Antibiotics, 2021 - mdpi.com
The β-lactams have a central place in the antibacterial armamentarium, but the increasing
resistance to these drugs, especially among Gram-negative bacteria, is becoming one of the …

New β-lactam–β-lactamase inhibitor combinations

D Yahav, CG Giske, A Grāmatniece… - Clinical microbiology …, 2020 - Am Soc Microbiol
The limited armamentarium against drug-resistant Gram-negative bacilli has led to the
development of several novel β-lactam–β-lactamase inhibitor combinations (BLBLIs). In this …

Discovery of an orally available diazabicyclooctane inhibitor (ETX0282) of class A, C, and D serine β-lactamases

TF Durand-Réville, J Comita-Prevoir… - Journal of Medicinal …, 2020 - ACS Publications
Multidrug resistant Gram-negative bacterial infections are an increasing public health threat
due to rapidly rising resistance toward β-lactam antibiotics. The hydrolytic enzymes called β …

Past and present perspectives on β-lactamases

K Bush - Antimicrobial agents and chemotherapy, 2018 - Am Soc Microbiol
ABSTRACT β-Lactamases, the major resistance determinant for β-lactam antibiotics in Gram-
negative bacteria, are ancient enzymes whose origins can be traced back millions of years …